NIH to Cut Back on Chimp Research

The NIH will significantly reduce the use of chimpanzees in biomedical research and retire the majority of its chimps to sanctuaries.

Written byChris Palmer
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

NIH plans to reduce its use of chimpanzees in biomedical research.WIKIMEDIA, THOMAS LERSCH

National Institutes of Health (NIH) director Francis Collins announced plans this morning (June 26) to accept and implement changes to its chimpanzee research program, as recommended in January by the Council of Councils, an independent working group of expert advisors. The recommendations were based on findings from a report about chimps’ use in research issued in December 2011 by the Institute of Medicine.

In accordance with the working group’s guidance, the NIH has decided to retire most of its approximately 360 chimpanzees currently housed in research laboratories to sanctuaries—a process that could take a couple of years. The agency plans to maintain, but not breed, a population of 50 animals for use in future research, but it has not decided which chimpanzees it will keep ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery